Clinical Trials in Jincheng, Shanxi
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 2
Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC
Extensive-stage Small-cell Lung Cancer
Second Hospital of Shanxi Medical University40 enrolled6 locationsNCT06536868
Recruiting
Not Applicable
Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Lesions
Coronary Artery Disease (CAD)Chronic Total Occlusions of Coronary Arterieschronic total occlusion (CTO)
The First Affiliated Hospital of Zhengzhou University200 enrolled18 locationsNCT07463664
Recruiting
Phase 2
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD)
Mabwell (Shanghai) Bioscience Co., Ltd.360 enrolled51 locationsNCT07292714
Recruiting
Phase 3
Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
Ischemic Stroke, Acute
Beijing Tiantan Hospital1,380 enrolled82 locationsNCT06157502
Recruiting
Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC
NSCLCRadiation PneumonitisNintedanib
Second Hospital of Shanxi Medical University40 enrolled7 locationsNCT06570317
Recruiting
Phase 4
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study
Non-small Cell Lung CancerCarcinomaAdenocarcinoma
Tian Xie744 enrolled7 locationsNCT04401059